Evidence map›Paper›PMID 22551351›Full record

ArticleBiochemistry2012

Structural dynamics of the amyloid β-protein monomer folding nucleus.

Robin Roychaudhuri, Mingfeng Yang, Margaret M Condron, David B Teplow

Abstract read
In one paragraph

Article in Biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The hairpin conformation of the amyloid β peptide is an important structural motif along the aggregation pathway.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2014
    Review
  6. Pulsed hydrogen-deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Robin RoychaudhuriDepartment of Neurology, University of California, Los Angeles, CA 90095, USA.
Mingfeng Yang
Margaret M Condron
David B Teplow

Funding

PROTEIN CHEMISTRY COREP01AG027818 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TEPLOW, DAVID B. · 2006 to 2010
$7.6M
STRUCTURAL/KINETIC ANALYSIS OF ABETA FIBRILLOGENESISR01NS038328 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TEPLOW, DAVID B. · 1999 to 2014
$4.0M
Physical Biochemistry and Biology of Amyloid Beta-ProteinR01AG041295 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TEPLOW, DAVID B. · 2011 to 2015
$1.6M
ApoE and Cholesterol Effects on Amyloid-beta in Synaptic Terminals in ADR01AG027465 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GYLYS, KAREN H · 2008 to 2012
$1.4M
ApoE and cholesterol effects on amyloid beta in synaptic terminals in ADR56AG027465 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GYLYS, KAREN H · 2015 to 2015
$385k
NIA NIH HHS AG027465NIA NIH HHS AG027818NIA NIH HHS AG041295NIA NIH HHS P01 AG027818NIA NIH HHS R01 AG027465NIA NIH HHS R01 AG041295NIA NIH HHS R56 AG027465NINDS NIH HHS NS038328NINDS NIH HHS R01 NS038328
6 · The paper itself

Abstract

Alzheimer's disease (AD) is linked to the aberrant assembly of the amyloid β-protein (Aβ). The (21)AEDVGSNKGA(30) segment, Aβ(21-30), forms a turn that acts as a monomer folding nucleus. Amino acid substitutions within this nucleus cause familial forms of AD. To determine the biophysical characteristics of the folding nucleus, we studied the biologically relevant acetyl-Aβ(21-30)-amide peptide using experimental techniques (limited proteolysis, thermal denaturation, urea denaturation followed by pulse proteolysis, and electron microscopy) and computational methods (molecular dynamics). Our results reveal a highly stable foldon and suggest new strategies for therapeutic drug development.

Indexed as

Protein FoldingAlzheimer DiseaseAmino Acid SubstitutionAmyloid beta-PeptidesHumansMolecular Dynamics SimulationPeptide FragmentsProtein ConformationProtein DenaturationProtein StabilityProteolysisAmyloid beta-Peptidesamyloid beta-protein (21-30)Peptide Fragments

Identifiers

PMID22551351
PMCPMC3362201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.